| |
|
|
|
Caladrius Bio  
|
|
2.0044 -0.006 (-0%) |
06-05 12:13 |
|
Open: |
2.02 |
Pre close: |
2.01 |
Target:
|
2.60
|
|
High: |
2.1 |
Low: |
1.98 |
Resistance:
|
2.22
2.60
|
|
Volume: |
392,920 |
Market Cap: |
30M |
Support:
|
1.61
1.34
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.98
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
1.95 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
2.29  |
Stochastic Oscillator |
%K(14,3):
|
49.59 |
|
MA(250): |
2.44 |
%D(3): |
43.64 |
|
Average Volume(K) |
3-Month: |
36256
|
52-Week |
High:
|
3.64 |
|
10-Days: |
120765 |
Low: |
1.05 |
|
RSI |
RSI(14):
|
51.47 |
Change(%): |
-28.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.812 |
Return on Equity (ttm) |
-73.8 |
Shares Out. (M) |
12.84 |
|
EPS Est. Current Year |
-2.420 |
Return on Assets (ttm) |
-38.5 |
Shares Float (M) |
9.67 |
|
EPS Est. Next Year |
-2.950 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.89 |
|
EPS Est. Next Quarter |
-0.770 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
20.84 |
|
Forward EPS |
-1.880 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
18 |
|
Book Value (p.s.) |
1.620 |
EBITDA (p.s.) |
-1.518 |
P/E |
-1.10 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.23 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-17.64 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-10.55 |
P/CF |
-1.46 |
|
|
|
|
|
|
